Volume : 12, Issue : 10, October – 2025
Title:
FORMULATION AND EVALUATION OF NANOSUSPENSION DRUG DELIVERY SYSTEM OF FLUCONAZOLE PRODUCED BY NANOPRECIPITATION METHOD
Authors :
Surna Ritish Kumar*, Dr. V. Anjaneyulu, I. Nagaraju, Dr. Vijay Kumar Gampa.
Abstract :
The present research aimed to develop & Evaluation of Fluconazole Nanosuspension. Fluconazole is a medication used to treat fungal infections. The formulated Nanosuspension was subjected to various evaluation parameters like particle size, polydispersity index, zeta potential, drug content, saturation solubility studies, In vitro release studies. The polydispersity ranged from 0.40 PDI to 1.36 PDI and zeta potential ranged from -17.51 mV to -35.42 mV are the important evaluation parameters are responsible for the stability of nanosuspensions. In this result, F3 formulation shows spectacular drug content range of 76.89 % to 98.97 % it is the maximum drug content. Fourier transform infrared spectroscopy indicated that there was no possible interaction between drug and polymer. In dissolution studies F3 formulation showed maximum drug release compared with other formulation. Hence F3 formulation was considered as optimised formulation. From this study, it was concluded that in recent advances in novel drug delivery system aims to enhance safety and efficacy of drug molecule by formulating a convenient dosage form for administration and to achieve better patient compliance, one such approach is Nanosuspension.
Keywords: Fluconazole, Carbopol, Ethyl Cellulose, Na CMC and Nanosuspension.
Cite This Article:
Please cite this article in press Surna Ritish Kumar et al., Formulation And Evaluation Of Nanosuspension Drug Delivery System Of Fluconazole Produced By Nanoprecipitation Method , Indo Am. J. P. Sci, 2025; 12(10).
REFERENCES:
1. Sathish Ummadi, B. Shravani, N. G. Raghavendra Rao, M. Srikanth Reddy, B. Sanjeev Nayak.
Overview on Controlled Release Dosage Form. International Journal of Pharma Sciences Vol. 3, No. 4 (2013): 258-269.
2. Brahmankar D.M. and Jaiswal S.B. (1995): “Biopharmaceutics and Pharmacokinetics” a Treatise. Vallabh Prakashan, First Edition; 336-337.
3. Lachman Leon, Lieberman Herbert A., Kanig Joseph L. (1996) “The theory and practice of industrial pharmacy” Second edition, Varghese publishing house; Bombay, 171-196.
4. Brahmankar DM, Jaiswal SB. Biopharmaceutics and Pharmacokinetics: Pharmacokinetics. 2nd ed. Vallabh Prakashan, Delhi: 2009; 399-401.
5. John C, Morten C, The Science of Dosage Form Design, Aulton: Modified release peroral dosage forms. 2nd ed. Churchill Livingstone. 2002; 290-300.
6. Ali Nokhodchi, Shaista Raja, Pryia Patel, and Kofi Asare-Addo. The Role of Oral Controlled Release Matrix Tablets in Drug Delivery Systems. Bioimpacts. 2012; 2(4): 175–187.
7. Md. Saddam Hussain, Abdul Baquee Ahmed and Jiban Debnath. Nanosuspension: A Promising Drug Delivery System For Poorly Water Soluble Drug And Enhanced Bioavailability. IJPSR, 2020; Vol. 11(10): 4822-4832.
8. Dhiman, Dharmila S and Thakur, GS: Nanosuspension: A recent approach for nano drug delivery system. Int J Curr Pharm Res 2017; 3(4).
9. Rinku Jayaprakash, K. Krishnakumar, B. Dineshkumar, Rejin Jose, Smitha K Nair. Nanosuspension in Drug Delivery-A Review. Sch. Acad. J. Pharm., 2016; 5(5): 138-141.
10. Wagh KS, Patil SK, Akarte AK, Baviskar DT; Nanosuspension – a new approach of bioavailability enhancement,International Journal of Pharmaceutical Sciences Review and Research, 2011; 8: 60-62.
11. Paun JS, Tank HM; Nanosuspension: An Emerging Trend for Bioavailability Enhancement of Poorly Soluble Drugs. Asian J. Pharm. Tech, 2012; 2(4):157-168.
12. Lakshmi P, Kumar GA; Nanosuspension technology: a review; International Journal of Pharmacy and Pharmaceutical Sciences, 2010; 2:35-40.
13. Praveen Kumar G, Krishna KG; Nanosuspensions: The Solution to Deliver Hydrophobic Drugs. International Journal of Drug Delivery, 2011; 3: 546-557.
14. Pattnaik S, Swain K, Rao JV; Nanosuspensions: a strategy for improved bioavailability. International Journal of Pharmacy and Biological Sciences, 2013; 3: 324-327.
15. Soumya M, Gupta S, Jain R, Mazumder R; Solubility enhancement of poorly water soluble drug by using nano suspension technology. International Journal of Research and Development in Pharmacy and Life Sciences. 2013; 2: 642-649.
16. Kavitha VB, Neethu CS, Dineshkumar B, Krishnakumar K, John A; Nanosuspension Formulation: An Improved Drug Delivery System. Nanoscience and Nanotechnology: An International Journal, 2014; 2: 1-5.
17. Arunkumar N, Deecarman M, Rani C; Nanosuspension technology and its application in drug delivery. Asian Journal of Pharmaceutics 2009; 3:168-173.
18. Komasaka T, Fujimura H, Tagawa T, Sugiyama A and Kitano Y, 2014, Practical method for preparing nanosuspension formulations for toxicology studies in the discovery stage: formulation optimization and in vitro/in vivo evaluation of nanosized poorly water-soluble compounds, Chemical and Pharmaceutical Bulletin, 62(11), 1073-1082, ISSN: 1347-5223.